← All news
Markets
Cambridge Cognition (LSE:COG) joins a new Alzheimer's diagnosis alliance this week: can digital tests shorten the wait?
Highlights Cambridge Cognition, a US blood-test developer and The Alzheimer's Trust formed a diagnosis partnership. The pathway pairs a blood test with the CANTAB Pathway digital cognitive assessment. UK clinicians can now order both throug…
Covered by 1 outlet
All coverage · 1 article